Market
Access
Since the introduction of the Arnzeimittelmarktneuordnungsgesetz (AMNOG) in 2011, market access professionals have played a key role in the introduction of new drugs and medical devices as well as in pricing.
-
Deutsch
-
English
Market
Already at an early stage in the development process, a potential additional benefit must be identified, which is then presented to the authorities and health insurance companies in the context of the market launch by means of a benefit dossier to show the value of the drug or medical device. The experts in this area must combine business knowledge with scientific expertise and have a thorough knowledge of the healthcare market and its political and legal framework. In addition, they must be able to negotiate effectively and confidently during the market launch process as well as in subsequent price negotiations. The ability to work with other departments across divisions rounds off the complex requirements profile for these positions.
Mr. Gunnar Mayr and Ms. Alina Kryzhanovskaya are our specialists for all positions in the area of market access.
Here's a small selection of positions that our consultants have successfully filled:
- Senior Manager Global HEOR
- Senior Manager HEOR & RWE
- Director Health Economics
- Senior Market Access Manager
- Senior Manager Pricing, Economics & Access Strategy
- Regional Market Access Lead
- Manager Market Access
- Head of Health Economics
- Director Global HEOR Oncology AML Franchise
